Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the aida protocol
Congestive Heart Failure, 05/03/2012Pellicori P et al.
Cardiac toxicity due to anthracycline therapy is often frequent. Changes in diastolic function are helpful in the detection of subclinical anthracycline cardiotoxicity in long–term cardiac follow–up despite a preserved systolic ventricular function.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.